Anna Feeney, MD

  • 3Articles
  • 36KReads
  • 2021–2022Active
  • 18Collaborators
  • 56Citations

About

Anna Feeney, MD, is affiliated with the Clinical Trials Network and Institute, Department of Psychiatry at Massachusetts General Hospital, and the Department of Psychiatry at Harvard Medical School. Her publications focus on major depressive disorder, specifically examining treatments such as intranasal esketamine, intravenous ketamine, and vortioxetine. Her work includes systematic reviews, meta-analyses, and clinical trial analyses of antidepressant effects and treatment interactions. Feeney has frequently collaborated with George I. Papakostas, Manish K. Jha, Maurizio Fava, Sanjay J. Mathew, and Dan V. Iosifescu.

Publications

JCP
Rapidity of Improvement With Intranasal Esketamine for MDD
Meta-Analysis

Rapidity of Improvement With Intranasal Esketamine for MDD

December 12, 2022

This meta-analysis found that augmenting antidepressants with intranasal esketamine vs placebo was more effective in reducing depression severity at 24 hours and study endpoint.
, , , et al
JCP
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
Original Research

Effect of Benzodiazepines on Antidepressant Effects of Ketamine

November 14, 2022

Findings of studies examining the impact of benzodiazepines on antidepressant effects of ketamine are contradictory. This study assessed whether concomitant oral benzodiazepines differentially affected treatment response to ketamine versus...
, , , et al
JCP
Meta-Analysis

Vortioxetine for Major Depressive Disorder

June 15, 2021

Prior meta-analyses have found vortioxetine to be efficacious for depression. Building on those findings, the present meta-analysis examined the effect that placebo response has on drug-placebo effect size in...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe